Same‐Day Discharge After Transcatheter Aortic Valve Implantation: Who, When, and How?

The burden of severe aortic stenosis requiring treatment is growing due to ageing populations. This places increased demands on health resources due to the growing number of transcatheter aortic valve implantation (TAVI) procedures and hospital bed occupancy. There are several studies of same-day discharge (SDD) after coronary angioplasty demonstrating its safety, particularly in transfemoral cases. There has been significant evolution in techniques and technologies underpinning TAVI, which have reduced its risk profile over time. As a result, several observational studies have demonstrated that SDD after TAVI is safe and effective. Careful selection of low-risk patients and a minimalist TAVI approach, with appropriate post-procedure review and follow-up, are crucial for successful SDD after TAVI. However, there is a need for randomised trials to validate this practice. This article provides a state-of-the-art overview and guidance to safely and effectively implement a SDD-TAVI service to improve the healthcare system efficiency while enhancing patient satisfaction and recovery.